RM Cherniack, TV Colby, A Flint, WM Thurlbeck, JA Waldron Jr, L Ackerson, MI Schwarz and TE King Jr
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, University of Colorado, Denver 80206.

The early stage of idiopathic pulmonary fibrosis (IPF) is thought to involve a smaller number of alveoli and to be characterized predominantly by cellularity and minimal fibrosis, whereas advanced disease involves a large number of alveoli and is characterized predominantly by fibrosis with minimal cellularity. In addition, correlative studies have indicated that prognosis and response to therapy is determined in part by the extent of fibrosis and cellularity. This study was undertaken to determine whether pulmonary function assessment would help distinguish between the cellular and fibrotic phases of this disorder, as determined by a semiquantitative pathology scoring system that comprised four factor scores: fibrosis, cellularity, granulation/connective tissue, and desquamation. Ninety- six untreated patients with biopsy-confirmed IPF (27 never smokers, 32 current smokers, and 37 ex-smokers) were evaluated. In the group as a whole, there was no significant relationship between the fibrosis or the connective/granulation tissue factor scores and any of the physiologic parameters. The DLCO correlated with the "desquamation" and the total pathology scores, whereas the TLC and FVC correlated with the cellularity factor score. In the current smokers, the coefficient of elastic retraction, DLCO/VA, and FEV1/FVC ratio were significantly lower than in never smokers and ex-smokers, and TLC and FVC were higher than in never smokers. Also, the mean cellularity and granulation/connective tissue factor scores were significantly lower, and the desquamation factor score was significantly higher than those in never smokers and ex-smokers. Both age and smoking status were significant for the cellularity factor score, whereas for the connective/granulation tissue factor score, age was not significant but smoking status was.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194. [Abstract] [Full Text] [PDF]

				H. Sahin, K. K. Brown, D. Curran-Everett, V. Hale, C. D. Cool, J. S. Vourlekis, and D. A. Lynch Chronic Hypersensitivity Pneumonitis: CT Features Comparison with Pathologic Evidence of Fibrosis and Survival Radiology, August 1, 2007; 244(2): 591 - 598. [Abstract] [Full Text] [PDF]

				F. J. Martinez Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia. Proceedings of the ATS, January 1, 2006; 3(1): 81 - 95. [Abstract] [Full Text] [PDF]

				F. J. Martinez and K. Flaherty Pulmonary function testing in idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 315 - 321. [Abstract] [Full Text] [PDF]

				D. W. Visscher and J. L. Myers Histologic spectrum of idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 322 - 329. [Abstract] [Full Text] [PDF]

				V. Cottin, H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur. Respir. J., October 1, 2005; 26(4): 586 - 593. [Abstract] [Full Text] [PDF]

				T. E. King Jr. Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 268 - 279. [Abstract] [Full Text] [PDF]

				V. N. Lama, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, Q. Long, S. Murray, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al. Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1084 - 1090. [Abstract] [Full Text] [PDF]

				P. Kumar, P. Goldstraw, K. Yamada, A. G. Nicholson, A. U. Wells, D. M. Hansell, R. M. duBois, and G. Ladas Pulmonary fibrosis and lung cancer: Risk and benefit analysis of pulmonary resection J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1321 - 1327. [Abstract] [Full Text]

				A. U. Wells, S. R. Desai, M. B. Rubens, N. S. L. Goh, D. Cramer, A. G. Nicholson, T. V. Colby, R. M. du Bois, and D. M. Hansell Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 962 - 969. [Abstract] [Full Text] [PDF]

				R.M. du Bois and A.U. Wells Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s. [Abstract] [Full Text] [PDF]

				S. C Bourke and H. Clague Review of cryptogenic fibrosing alveolitis, including current treatment guidelines Postgrad. Med. J., October 1, 2000; 76(900): 618 - 624. [Full Text]

				J. E. Michaelson, S. M. Aguayo, and J. Roman Idiopathic Pulmonary Fibrosis : A Practical Approach for Diagnosis and Management Chest, September 1, 2000; 118(3): 788 - 794. [Full Text] [PDF]

				D. W Mapel, W. C Hunt, R. Utton, K. B Baumgartner, J. M Samet, and D. B Coultas Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts Thorax, June 1, 1998; 53(6): 469 - 476. [Abstract] [Full Text]

				S. E. GAY, E. A. KAZEROONI, G. B. TOEWS, J. P. LYNCH III, B. H. GROSS, P. N. CASCADE, D. L. SPIZARNY, A. FLINT, M. ANTHONY SCHORK, R. I. WHYTE, et al. Idiopathic Pulmonary Fibrosis . Predicting Response to Therapy and Survival Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1063 - 1072. [Abstract] [Full Text] [PDF]

				A.-L. A. KATZENSTEIN and J. L. MYERS Idiopathic Pulmonary Fibrosis . Clinical Relevance of Pathologic Classification Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1301 - 1315. [Full Text] [PDF]

				P. A. WARD and G. W. HUNNINGHAKE Lung Inflammation and Fibrosis Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S123 - S129. [Full Text] [PDF]

				Corrigenda for vol. 155, p. 1367 Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 676 - 677. [Full Text]